The Patent Finder

Chiba Prefecture

Also on record
Records under this name other than the patents Chiba Prefecture holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Chiba Prefecture

PatentTitleStatus Expires Confidence
US 11,193,172Method for Predicting Prognosis of Patient with Cancer or Inflammatory Disease
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,185,593Alkylating agent for alkylating target with driver oncogene mutation
Lapsed on the fee record
Ended Nov 30, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 30, 2025From the USPTO record
US 10,751,421Alkylating agent for alkylating target with driver oncogene mutation
Lapsed on the fee record
Ended Aug 25, 2024 · From the USPTO record
Lapsed on the fee recordEnded Aug 25, 2024From the USPTO record
US 7,625,711Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease
Lapsed on the fee record
Ended Dec 1, 2021 · From the USPTO record
Lapsed on the fee recordEnded Dec 1, 2021From the USPTO record
US 7,601,532Microarray for Predicting the Prognosis of Neuroblastoma and Method for Predicting the Prognosis of Neuroblastoma
Lapsed on the fee record
Ended Oct 13, 2021 · High confidence
Lapsed on the fee recordEnded Oct 13, 2021High confidence
US 7,087,383Nucleic Acid Sequences Showing Enhanced Expression in Benign Neuroblastoma Compared with Acritical Human Neuroblastoma
Term ended
Term ended Mar 2, 2021 · High confidence
Term endedTerm ended Mar 2, 2021High confidence
US 7,429,451Nucleic acids isolated from stage 4 neuroblastoma
Formerly held
Lapsed on the fee record
Ended Sep 30, 2020 · From the USPTO record
Lapsed on the fee recordEnded Sep 30, 2020From the USPTO record
US 8,202,690Cancer Marker and Therapeutic Agent for Cancer
Lapsed on the fee record
Ended Jun 19, 2020 · High confidence
Lapsed on the fee recordEnded Jun 19, 2020High confidence
US 7,384,750Nucleic Acid Sequences Having Characteristics of Enhanced Expression in Human Neuroblastoma with Favorable Prognosis Based on Comparison Between Human Neuroblastoma with Favorable Prognosis and Human Neuroblastoma with Unfavorable Prognosis
Lapsed on the fee record
Ended Jun 10, 2020 · High confidence
Lapsed on the fee recordEnded Jun 10, 2020High confidence
US 7,335,755Nucleic Acids Isolated in Neuroblastoma
Lapsed on the fee record
Ended Feb 26, 2020 · High confidence
Lapsed on the fee recordEnded Feb 26, 2020High confidence
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited